Cero Therapeutics Holdings, Inc. issued a convertible promissory note for $750,000 with a face value of $937,500 on February 9, 2026. The note has a 10% interest rate and is convertible to shares at a price capped at $0.05, potentially allowing borrowing up to $1 million.